An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 12 (1) , 203-210.e1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- National Heart, Lung, and Blood Institute (HL087228, HL090553)
- Fondation Leducq (12CVD04)
This publication has 29 references indexed in Scilit:
- Deletion of GPIHBP1 causing severe chylomicronemiaJournal of Inherited Metabolic Disease, 2011
- GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into CapillariesCell Metabolism, 2010
- Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemiaJournal of Lipid Research, 2010
- Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 DefectsCirculation: Cardiovascular Genetics, 2010
- Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein LipaseArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of ChylomicronsCell Metabolism, 2007
- Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in SerumClinical Chemistry, 2006
- Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase ReceptorClinical Chemistry, 2004
- Expression Cloning and Characterization of a Novel Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein, GPI-HBP1Journal of Biological Chemistry, 2003
- IDIOPATHIC HYPERLIPEMIA: METABOLIC STUDIES IN AN AFFECTED FAMILY*Journal of Clinical Investigation, 1960